本页面由Tiger Trade Technology Pte. Ltd.提供服务

Caris Life Sciences, Inc.

29.69
-0.0100-0.03%
盘后:29.690.00000.00%19:30 EDT
成交量:499.76万
成交额:1.47亿
市值:83.77亿
市盈率:79.81
高:30.13
开:29.94
低:28.49
收:29.70
52周最高:33.65
52周最低:14.19
股本:2.82亿
流通股本:1.16亿
量比:1.06
换手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
净资产收益率:20.13%
总资产收益率:8.77%
市净率:14.16
市盈率(LYR):-9.22

数据加载中...

2020/08/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/07/29

重要事件披露

8-K - Current report
2020/07/08

重要事件披露

8-K - Current report
2020/06/15

重要事件披露

8-K - Current report
2020/05/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/06

重要事件披露

8-K/A [Amend] - Current report
2020/03/05

重要事件披露

Current report, items 2.02 and 9.01
2020/03/05

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/29

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/22

超过5%披露

[Amend] General statement of acquisition of beneficial ownership